Concepedia

Anna Buder

AB

9

Publications

338

Citations

9

H-Index

2018

Active since

Affiliations

Medical University of Vienna(Current)

Comprehensive Cancer Center Vienna

Otto Wagner Hospital

Ludwig Boltzmann Institute for Lung Health

Medical University of Graz

Anna Buder is an author at Medical University of Vienna specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2018–2021

9

Publications

9

Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

Maximilian J. Hochmair, Anna Buder, Sophia Schwab et al. · Targeted Oncology · 2018 · 105 citations · Full text

Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC

Anna Buder, Maximilian J. Hochmair, Sophia Schwab et al. · Journal of Thoracic Oncology · 2018 · 64 citations · Full text

, , +5

EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR

Anna Buder, Ulrike Setinek, Maximilian J. Hochmair et al. · Targeted Oncology · 2019 · 42 citations · Full text

Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study

Luka Brčić, Thomas Klikovits, Zsolt Megyesfalvi et al. · Translational Lung Cancer Research · 2021 · 29 citations · Full text

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

Anna Buder, Maximilian J. Hochmair, Ulrike Setinek et al. · Translational Lung Cancer Research · 2020 · 28 citations · Full text

Rows per page

1–5 of 9